iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/23488511/
Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009 - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May;103(5):917-22.
doi: 10.2105/AJPH.2012.301049. Epub 2013 Mar 14.

Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009

Affiliations

Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009

Robert P Schwartz et al. Am J Public Health. 2013 May.

Abstract

Objectives: We examined the association between the expansion of methadone and buprenorphine treatment and the prevalence of heroin overdose deaths in Baltimore, Maryland from 1995 to 2009.

Methods: We conducted a longitudinal time series analysis of archival data using linear regression with the Newey-West method to correct SEs for heteroscedasticity and autocorrelation, adjusting for average heroin purity.

Results: Overdose deaths attributed to heroin ranged from a high of 312 in 1999 to a low of 106 in 2008. While mean heroin purity rose sharply (1995-1999), the increasing number of patients treated with methadone was not associated with a change in the number of overdose deaths, but starting in 2000 expansion of opioid agonist treatment was associated with a decline in overdose deaths. Adjusting for heroin purity and the number of methadone patients, there was a statistically significant inverse relationship between heroin overdose deaths and patients treated with buprenorphine (P = .002).

Conclusions: Increased access to opioid agonist treatment was associated with a reduction in heroin overdose deaths. Implementing policies that support evidence-based medication treatment of opiate dependence may decrease heroin overdose deaths.

PubMed Disclaimer

Figures

FIGURE 1—
FIGURE 1—
Heroin overdose deaths and opioid agonist treatment: Baltimore, MD, 1995–2009.

Comment in

  • Schwartz et al. respond.
    Schwartz RP, Gryczynski J, O'Grady KE, Sharfstein JM, Warren G, Olsen YK, Mitchell SG, Jaffe JH. Schwartz RP, et al. Am J Public Health. 2013 Aug;103(8):e2-3. doi: 10.2105/AJPH.2013.301428. Epub 2013 Jun 13. Am J Public Health. 2013. PMID: 23763406 Free PMC article. No abstract available.
  • Efforts to reduce overdose deaths.
    Sherman SG, Han J, Welsh C, Chaulk P, Serio-Chapman C. Sherman SG, et al. Am J Public Health. 2013 Aug;103(8):e1-2. doi: 10.2105/AJPH.2013.301410. Epub 2013 Jun 13. Am J Public Health. 2013. PMID: 23763429 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Darke S, Hall W. Heroin overdose: research and evidence-based intervention. J Urban Health. 2003;80(2):189–200 - PMC - PubMed
    1. Hickman M, Carrivick S, Paterson Set al.London audit of drug-related overdose deaths: characteristics and typology, and implications for prevention and monitoring. Addiction. 2007;102(2):317–323 - PubMed
    1. Preti A, Miotto P, De Coppi M. Deaths by unintentional illicit drug overdose in Italy, 1984–2000. Drug Alcohol Depend. 2002;66(3):275–282 - PubMed
    1. World Health Organization Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention. Vienna: United Nations Office on Drugs and Crime; 2004
    1. Darke S, Duflou J, Torok M. A reduction in blood morphine concentrations amongst heroin overdose fatalities associated with a sustained reduction in street heroin purity. Forensic Sci Int. 2010;198(1–3):118–120 - PubMed

MeSH terms